Novartis and Malaria No More Campaign Provide Antimalarial Treatments in Zambia - - BioPharm International

ADVERTISEMENT

Novartis and Malaria No More Campaign Provide Antimalarial Treatments in Zambia



Novartis reported that 2 million treatments of its pediatric antimalarial are arriving in Zambia due to collaboration with Malaria No More's Power of One campaign, a global digital fundraising operation. Zambia is the first beneficiary country of this campaign sponsored by Novartis. One million treatments of coartem dispersible have been funded through public donations and Novartis matched these with a further one million treatments.

The campaign, which launched to the public in September 2013, uses social, mobile, and e-commerce technologies, enabling the public to purchase treatments for children in Zambia. Novartis is supporting the campaign financially and has pledged to match up to one million treatments funded by the public every year through 2015. Since 2009, Novartis has delivered over 600 million treatments, of which more than 200 million were treatments developed specifically for children, without profit to malaria-endemic countries.

Source: Novartis

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines

Click here